English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
ASCO 2024: Innovative combination therapy shows promise for bladder cancer patients unresponsive to standard treatment
ASCO 2024: Innovative combination therapy shows promise for bladder cancer patients unresponsive to standard...
New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells
New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells
Researchers identify key differences in inner workings of immune cells
Researchers identify key differences in inner workings of immune cells
ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%
ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%
White blood cell 'nets' could be early warning sign of major immunotherapy complication
White blood cell 'nets' could be early warning sign of major immunotherapy complication
Two-pronged attack strategy boosts immunotherapy in preclinical studies
Two-pronged attack strategy boosts immunotherapy in preclinical studies
ASCO 2024: Promising results from the first clinical trial of an innovative next-generation antibody in patients with advanced solid tumours, especially in melanoma
ASCO 2024: Promising results from the first clinical trial of an innovative next-generation antibody in patients...
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
ASCO 2024: New ‘Armoured’ CAR produces significant responses in patients whose cancers don't respond to current CAR T cell therapies
ASCO 2024: New ‘Armoured’ CAR produces significant responses in patients whose cancers don't respond to current...
ASCO 2024: Experimental therapy shows promise in pancreatic cancer clinical trial
ASCO 2024: Experimental therapy shows promise in pancreatic cancer clinical trial
<1...3132333435...358>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top